2024-07-092025-03-312025-03-31false15829260CRAWLEY CLINIC LTD2025-06-24falseiso4217:GBPxbrli:pure158292602024-07-09158292602025-03-31158292602024-07-092025-03-31158292602024-07-08158292602024-07-08158292602024-07-082024-07-0815829260bus:SmallEntities2024-07-092025-03-3115829260bus:AuditExempt-NoAccountantsReport2024-07-092025-03-3115829260bus:FullAccounts2024-07-092025-03-3115829260bus:PrivateLimitedCompanyLtd2024-07-092025-03-3115829260core:WithinOneYear2025-03-3115829260core:AfterOneYear2025-03-3115829260core:WithinOneYear2024-07-0815829260core:AfterOneYear2024-07-0815829260core:ShareCapital2025-03-3115829260core:SharePremium2025-03-3115829260core:RevaluationReserve2025-03-3115829260core:OtherReservesSubtotal2025-03-3115829260core:RetainedEarningsAccumulatedLosses2025-03-3115829260core:ShareCapital2024-07-0815829260core:SharePremium2024-07-0815829260core:RevaluationReserve2024-07-0815829260core:OtherReservesSubtotal2024-07-0815829260core:RetainedEarningsAccumulatedLosses2024-07-0815829260core:LandBuildings2025-03-3115829260core:PlantMachinery2025-03-3115829260core:Vehicles2025-03-3115829260core:FurnitureFittings2025-03-3115829260core:OfficeEquipment2025-03-3115829260core:NetGoodwill2025-03-3115829260core:IntangibleAssetsOtherThanGoodwill2025-03-3115829260core:ListedExchangeTraded2025-03-3115829260core:UnlistedNon-exchangeTraded2025-03-3115829260core:LandBuildings2024-07-0815829260core:PlantMachinery2024-07-0815829260core:Vehicles2024-07-0815829260core:FurnitureFittings2024-07-0815829260core:OfficeEquipment2024-07-0815829260core:NetGoodwill2024-07-0815829260core:IntangibleAssetsOtherThanGoodwill2024-07-0815829260core:ListedExchangeTraded2024-07-0815829260core:UnlistedNon-exchangeTraded2024-07-0815829260core:LandBuildings2024-07-092025-03-3115829260core:PlantMachinery2024-07-092025-03-3115829260core:Vehicles2024-07-092025-03-3115829260core:FurnitureFittings2024-07-092025-03-3115829260core:OfficeEquipment2024-07-092025-03-3115829260core:NetGoodwill2024-07-092025-03-3115829260core:IntangibleAssetsOtherThanGoodwill2024-07-092025-03-3115829260core:ListedExchangeTraded2024-07-092025-03-3115829260core:UnlistedNon-exchangeTraded2024-07-092025-03-3115829260core:MoreThanFiveYears2024-07-092025-03-3115829260core:Non-currentFinancialInstruments2025-03-3115829260core:Non-currentFinancialInstruments2024-07-0815829260dpl:CostSales2024-07-092025-03-3115829260dpl:DistributionCosts2024-07-092025-03-3115829260core:LandBuildings2024-07-092025-03-3115829260core:PlantMachinery2024-07-092025-03-3115829260core:Vehicles2024-07-092025-03-3115829260core:FurnitureFittings2024-07-092025-03-3115829260core:OfficeEquipment2024-07-092025-03-3115829260dpl:AdministrativeExpenses2024-07-092025-03-3115829260core:NetGoodwill2024-07-092025-03-3115829260core:IntangibleAssetsOtherThanGoodwill2024-07-092025-03-3115829260dpl:GroupUndertakings2024-07-092025-03-3115829260dpl:ParticipatingInterests2024-07-092025-03-3115829260dpl:GroupUndertakingscore:ListedExchangeTraded2024-07-092025-03-3115829260core:ListedExchangeTraded2024-07-092025-03-3115829260dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-07-092025-03-3115829260core:UnlistedNon-exchangeTraded2024-07-092025-03-3115829260dpl:CostSales2024-07-082024-07-0815829260dpl:DistributionCosts2024-07-082024-07-0815829260core:LandBuildings2024-07-082024-07-0815829260core:PlantMachinery2024-07-082024-07-0815829260core:Vehicles2024-07-082024-07-0815829260core:FurnitureFittings2024-07-082024-07-0815829260core:OfficeEquipment2024-07-082024-07-0815829260dpl:AdministrativeExpenses2024-07-082024-07-0815829260core:NetGoodwill2024-07-082024-07-0815829260core:IntangibleAssetsOtherThanGoodwill2024-07-082024-07-0815829260dpl:GroupUndertakings2024-07-082024-07-0815829260dpl:ParticipatingInterests2024-07-082024-07-0815829260dpl:GroupUndertakingscore:ListedExchangeTraded2024-07-082024-07-0815829260core:ListedExchangeTraded2024-07-082024-07-0815829260dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-07-082024-07-0815829260core:UnlistedNon-exchangeTraded2024-07-082024-07-0815829260core:NetGoodwill2025-03-3115829260core:IntangibleAssetsOtherThanGoodwill2025-03-3115829260core:LandBuildings2025-03-3115829260core:PlantMachinery2025-03-3115829260core:Vehicles2025-03-3115829260core:FurnitureFittings2025-03-3115829260core:OfficeEquipment2025-03-3115829260core:AfterOneYear2025-03-3115829260core:WithinOneYear2025-03-3115829260core:ListedExchangeTraded2025-03-3115829260core:UnlistedNon-exchangeTraded2025-03-3115829260core:ShareCapital2025-03-3115829260core:SharePremium2025-03-3115829260core:RevaluationReserve2025-03-3115829260core:OtherReservesSubtotal2025-03-3115829260core:RetainedEarningsAccumulatedLosses2025-03-3115829260core:NetGoodwill2024-07-0815829260core:IntangibleAssetsOtherThanGoodwill2024-07-0815829260core:LandBuildings2024-07-0815829260core:PlantMachinery2024-07-0815829260core:Vehicles2024-07-0815829260core:FurnitureFittings2024-07-0815829260core:OfficeEquipment2024-07-0815829260core:AfterOneYear2024-07-0815829260core:WithinOneYear2024-07-0815829260core:ListedExchangeTraded2024-07-0815829260core:UnlistedNon-exchangeTraded2024-07-0815829260core:ShareCapital2024-07-0815829260core:SharePremium2024-07-0815829260core:RevaluationReserve2024-07-0815829260core:OtherReservesSubtotal2024-07-0815829260core:RetainedEarningsAccumulatedLosses2024-07-0815829260core:NetGoodwill2024-07-0815829260core:IntangibleAssetsOtherThanGoodwill2024-07-0815829260core:LandBuildings2024-07-0815829260core:PlantMachinery2024-07-0815829260core:Vehicles2024-07-0815829260core:FurnitureFittings2024-07-0815829260core:OfficeEquipment2024-07-0815829260core:AfterOneYear2024-07-0815829260core:WithinOneYear2024-07-0815829260core:ListedExchangeTraded2024-07-0815829260core:UnlistedNon-exchangeTraded2024-07-0815829260core:ShareCapital2024-07-0815829260core:SharePremium2024-07-0815829260core:RevaluationReserve2024-07-0815829260core:OtherReservesSubtotal2024-07-0815829260core:RetainedEarningsAccumulatedLosses2024-07-0815829260core:AfterOneYear2024-07-092025-03-3115829260core:WithinOneYear2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:CostValuation2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-092025-03-3115829260core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3115829260core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3115829260core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3115829260core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3115829260core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3115829260core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3115829260core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3115829260core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3115829260core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3115829260core:Non-currentFinancialInstrumentscore:CostValuation2024-07-0815829260core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-0815829260core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-0815829260core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-0815829260core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-0815829260core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-0815829260core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-0815829260core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-0815829260core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-0815829260bus:Director12024-07-092025-03-3115829260bus:Director22024-07-092025-03-31

CRAWLEY CLINIC LTD

Registered Number
15829260
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2025

CRAWLEY CLINIC LTD
Company Information
for the period from 9 July 2024 to 31 March 2025

Directors

EYRUMLU, Azad, Dr
SHAKIR, Honar

Registered Address

74 Pentland Road
Slough
SL2 1TN

Registered Number

15829260 (England and Wales)
CRAWLEY CLINIC LTD
Balance Sheet as at
31 March 2025

Notes

2025

£

£

Fixed assets
Tangible assets3167,916
167,916
Current assets
Debtors4197,956
Cash at bank and on hand153,950
351,906
Creditors amounts falling due within one year5(359,366)
Net current assets (liabilities)(7,460)
Total assets less current liabilities160,456
Net assets160,456
Capital and reserves
Called up share capital1
Profit and loss account160,455
Shareholders' funds160,456
The financial statements were approved and authorised for issue by the Board of Directors on 24 June 2025, and are signed on its behalf by:
EYRUMLU, Azad, Dr
Director
SHAKIR, Honar
Director

Registered Company No. 15829260
CRAWLEY CLINIC LTD
Notes to the Financial Statements
for the period ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

2025
Average number of employees during the year2
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
Additions167,916167,916
At 31 March 25167,916167,916
Net book value
At 31 March 25167,916167,916
At 08 July 24--
4.Debtors: amounts due within one year

2025

£
Trade debtors / trade receivables82,746
Other debtors115,210
Total197,956
5.Creditors: amounts due within one year

2025

£
Trade creditors / trade payables185,786
Finance lease and HP contracts173,580
Total359,366
6.Creditors: amounts due after one year
7.Related party transactions
The intercompany balances consist entirely of related party transactions, which form part of the ultimate controlling party. The accumulated balance as at year end, owed by the company is £40,415.
8.Controlling party
The ultimate controlling party is Silicate Ltd.